Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma

Life Sciences

Volumn 78, Issue 22, 2006, Pages 2643-2649

  Zhou, Jian hong ^a   Ye, Feng ^a   Chen, Huai zeng ^a   Zhou, Cai yun ^a   Lu, Wei guo ^a   Xie, Xing ^a  

^a Womens Hospital   (China)

Author keywords

CD99; Cervical neoplasms; HLA DR; HLA G; Ki67

Indexed keywords

ANTIBODY; CD99 ANTIGEN; HLA ANTIBODY; HLA DR ANTIGEN; HLA G ANTIGEN; KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER INVASION; CELL MEMBRANE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33646030601     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.10.039     Document Type: Article

References (44)

1. Benton C., Shahidulla H., and Hunter J. Human papillomavirus in the immunosuppressed. Papillomavirus Report 3 1 (1992) 23-26
2. Bernard G., Breittmayer J.P., de Matteis M., Trampont P., Hofman P., Senik A., and Bernard A. Apoptosis of immature thymocytes mediated by E2/CD99. Journal of Immunology 158 6 (1997) 2543-2550
3. Blaschitz A., Hutter H., Leitner V., Pilz S., Wintersteiger R., Dohr G., and Sedlmayr P. Reaction patterns of monoclonal antibodies to HLA-G in human tissues and on cell lines: a comparative study. Human Immunology 61 11 (2000) 1074-1085
4. Choi E.Y., Park W.S., Jung K.C., Kim S.H., Kim Y.Y., Lee W.J., and Park S.H. Engagement of CD99 induces up-regulation of TCR and MHC class I and II molecules on the surface of human thymocytes. Journal of Immunology 161 2 (1998) 749-754
5. Choi Y.L., Kim H.S., and Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Archives of Pathology and Laboratory Medicine 124 4 (2000) 563-569
6. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., and Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. Journal of Experimental Medicine 186 2 (1997) 289-298
7. Davidson B., Goldberg I., Lerner-Geva L., Gotlieb W.H., Ben-Baruch G., Novikov I., and Kopolovic J. Expression of topoisomerase II and Ki67 in cervical carcinoma-clinopathological study using immunohistochemistry. APMIS 108 3 (2000) 209-215
8. Dworzak M.N., Fritsch G., Fleischer C., Printz D., Froschl G., Buchinger P., Mann G., and Gadner H. CD99 (MIC2) expression in pediatric B-lineage leukaemia/lymphoma reflects maturation-associated patterns of normal B-lymphopoiesis. British Journal of Haematology 105 3 (1999) 690-695
9. Ferenczy A., and Wright T.C. Anatomy and histology of the cervix. In: Kurman R.J. (Ed). Blaustein's Pathology of the Female Genital Tract. 4th ed. (1994), Springer-Verlag, New York 185-201
10. Fidler H.K., Boyes D.A., and Worth A.J. Cervical cancer detection in British Columbia. A progress report. Journal of Obstetrics and Gynaecology of the British Commonwealth 75 4 (1968) 392-404
11. Folpe A.L., Hill C.E., Parham D.M., O'Shea P.A., and Weiss S.W. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. American Journal of Surgical Pathology 24 12 (2000) 1657-1662
12. Folpe A.L., McKenney J.K., Bridge J.A., and Weiss S.W. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. American Journal of Surgical Pathology 26 9 (2002) 1175-1183
13. Frumento G., Franchello S., Geraghty E., and Ferrara G.B. Analysis of HLA-G expression in tumor cell lines. Transplantation Proceedings 31 4 (1999) 1847-1848
14. Fukushima Y., Oshika Y., Nakamura M., Tokunaga T., Hatanaka H., Abe Y., Yamazaki H., Kijima H., Ueyama Y., and Tamaoki N. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells. International Journal of Molecular Medicine 2 3 (1998) 349-351
15. Goldman-Wohl D.S., Ariel I., Greenfield C., Hanoch J., and Yagel S. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation; a lesson learned from ectopic pregnancies. Molecular Human Reproduction 6 6 (2000) 535-540
16. Hahn J.H., Kim M.K., Choi E.Y., Kim S.H., Sohn H.W., Ham D.I., Chung D.H., Kim T.J., Lee W.J., Park C.K., Ree H.J., and Park S.H. CD99(MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. Journal of Immunology 159 5 (1997) 2250-2258
17. Hughes R.G., Norval M., and Howie M. Expression of major histocompatibility class II antigens by Langerhans cells in cervical intraepithelial neoplasia. Journal of Clinical Pathology 41 3 (1988) 253-259
18. Ibrahim E.C., Guerra N., Terrier Lacombe M.J., Angevin E., Chouaib S., Carosella E.D., Caignard A., and Paul P. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Research 61 18 (2001) 6838-6845
19. Isacson C., Kessis T.D., Hedrick L., and Cho K.R. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Research 56 4 (1996) 669-674
20. Kim S.H., Shin Y.K., Lee I.S., Bae Y.M., Sohn H.W., Suh Y.H., Ree H.J., Rowe M., and Park S.H. Viral latent membrane protein 1(LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 95 1 (2000) 294-300
21. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 4952 (1990) 220-223
22. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D., and Paul P. Specific activation of the nonclassical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Journal of Pathology 196 3 (2002) 266-274
23. Lila N., Carpentier A., Amrein C., Khalil-Daher I., Dausset J., and Carosella E.D. Implication of HLA-G molecule in heartgraft acceptance. Lancet 355 9221 (2000) 2138
24. Lopez-Botet M., Navarro F., and Llano M. How do NK cells sense the expression of HLA-G class Ib molecules?. Seminars in Cancer Biology 9 1 (1999) 19-26
25. Matsumoto M., Komiyama K., Okaue M., Shimoyama Y., Iwakami K., Namaki S., Tanaka H., Mono I., and Sato H. Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67. Journal of Oral Science 41 2 (1999) 53-56
26. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., Carosella E.D., and Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. International Immunology 11 5 (1999) 803-811
27. Mota F.F., Rayment N.B., Kanan J.H., Singer A., and Chain B.M. Differential regulation of HLA-DR expression by keratinocytes and Langerhans cells in normal and premalignant cervical epithelium. Tissue Antigens 52 3 (1998) 286-293
28. Munoz N. Human papillomavirus and cervical cancer: epidemiological evidence. In: Franco E., and Monsonego J. (Eds). New Developments in Cervical Cancer Screening and Prevention (1997), Blackwell Science, Ltd., Oxford 3-13
29. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., and Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. Journal of Immunology 164 12 (2000) 6426-6434
30. Pangault C., Amiot L., Caulet-Maugendre S., Brasseur F., Burtin F., Guilloux V., Drenou B., Fauchet R., and Onno M. HLA-G protein expression is not induced during malignant transformation. Tissue Antigens 53 4 pt 1 (1999) 335-346
31. Pangault C., Le Friec G., Caulet-Maugendre S., Lena H., Amiot L., Guilloux V., Onno M., and Fauchet R. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Human Immunology 63 2 (2002) 83-90
32. Paul P., Cabestre F.A., Le Gal F.-A., Khalil-Daher I., Le Danff C., Schmid M., Mercier S., Avril M.F., Dausset J., Guillet J.G., and Carosella E.D. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Research 59 8 (1999) 1954-1960
33. Payne S., Kernohan N.M., and Walker F. Proliferation in the normal cervix and in preinvasive cervical lesions. Journal of Clinical Pathology 49 8 (1996) 667-671
34. Real L.M., Cabrera T., Collado A., Jimenez P., Garcia A., Ruiz-Cabello F., and Garrido F. Expression of HLA-G in human tumors is not a frequent event. International Journal of Cancer 81 4 (1999) 512-518
35. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proceedings of the National Academy of Sciences of the United States of America 94 21 (1997) 11520-11525
36. Rouas-Freiss N., Khalil-Daher I., Riteau B., Menier C., Paul P., Dausset J., and Carosella E.D. The immunotolerance role of HLA-G. Seminars in Cancer Biology 9 1 (1999) 3-12
37. Schneider J., Gonzalez-Roces S., Pollan M., Lucas R., Tejerina A., Martin M., and Alba A. Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy. Breast Cancer Research 3 3 (2001) 183-191
38. Sinicrope F.A., Ruan S.B., Cleary K.B., Stephens C., Lee J.J., and Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Research 55 2 (1995) 237-241
39. Spriggs A.I., and Boddington M.M. Progression and regression of cervical lesions: review of smears from women followed without initial biopsy or treatment. Journal of Clinical Pathology 33 6 (1980) 517-525
40. Urosevic M., Willers J., Mueller B., Kempf W., Burg G., and Dummer R. HLA-G protein up-regulation in primary cutaneous lymphoma is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99 2 (2002) 609-617
41. Viac J., Soler C., Chardonnet Y., Euvrard S., and Schmitt D. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions. Immunobiology 188 4-5 (1993) 392-402
42. Wright T.C., Ferenczy A., and Kurman R.J. Carcinoma and other tumors of the cervix. In: Kurman R.J. (Ed). Blaustein's Pathology of the Female Genital Tract. 4th ed. (1994), Springer-Verlag Ltd., New York 279-326
43. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184 1 (1991) 9-13
44. Zur-Hausen H. Papilloma viruses in human cancer. Proceedings of Association of American Physicians 111 6 (1999) 581-587